887
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis

, , &
Pages 213-220 | Accepted 24 Oct 2012, Published online: 08 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jane Roche, Yvonne McCarry & Karen Mellors. (2014) Enhanced patient support services improve patient persistence with multiple sclerosis treatment. Patient Preference and Adherence 8, pages 805-811.
Read now

Articles from other publishers (11)

Aliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, Carlo Tornatore, Natalie C. Edwards, Yvette Lipman & Amy L. Phillips. (2023) Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review. International Journal of MS Care 25:5, pages 188-195.
Crossref
Sara Hamtaeigashti, Mohsen Shamsi, Mohammad Ali Sahraian, Raheleh Soltani & Amir Almasi-Hashiani. (2023) Effect of an educational intervention based on the theory of planned behavior on improving medication adherence in patients with multiple sclerosis treated with injectable disease-modifying drugs: randomized controlled trial. BMC Public Health 23:1.
Crossref
Mattea Tan Thompson, Devonshire Virginia, Belviso Nick, Gillen Melissa, Noella Engineer, Changyu Shen & Scott Reedie. (2022) Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program. Multiple Sclerosis and Related Disorders 67, pages 104080.
Crossref
Serena Barello, Damiano Paolicelli, Roberto Bergamaschi, Salvatore Cottone, Alessandra D'Amico, Viviana Annibali, Andrea Paolillo, Caterina Bosio, Valentina Panetta & Guendalina Graffigna. (2022) A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva® PSP. Frontiers in Psychology 13.
Crossref
Joshua MardanMohammad Akhtar HussainMichelle AllanLisa B Grech. (2021) Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression. Journal of Managed Care & Specialty Pharmacy 27:9, pages 1273-1295.
Crossref
Daniel Golan, Smadar Sagiv, Lea Glass-Marmor & Ariel Miller. (2020) Mobile phone-based e-diary for assessment and enhancement of medications adherence among patients with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:3, pages 205521732093930.
Crossref
Florian Lenz & Lutz Harms. (2020) The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study. Advances in Therapy 37:6, pages 2999-3009.
Crossref
Daniel R. Wynn. (2019) Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use. Multiple Sclerosis International 2019, pages 1-19.
Crossref
Kristina F Simacek, John J Ko, Debbie Moreton, Stefan Varga, Kristen Johnson & Bozena J Katic. (2018) The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study. Journal of Medical Internet Research 20:10, pages e11168.
Crossref
Peter Greiner, Anna Sawka & Emma Imison. (2015) Patient and Physician Perspectives on MSdialog, an Electronic PRO Diary in Multiple Sclerosis. The Patient - Patient-Centered Outcomes Research 8:6, pages 541-550.
Crossref
Kathy FranklinEmma MatthewsKaren Mellors. (2014) A retrospective UK audit assessing the effect of the MySupport programme on patient persistence with MS treatment. British Journal of Neuroscience Nursing 10:3, pages 124-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.